Migraine and the temporomandibular joint: the final answer?
Explore the source record for details and available documents.
Adolescent↗
Biomedical subjects
K M Peet
Publications and source records attributed to K M Peet.
Decreased platelet 3H-imipramine binding sites in classical migraine.
Patients with classical migraine investigated between attacks had significantly fewer platelet 3H-imipramine binding sites than control subjects and this finding was more marked in males than in females. There was no abnormality of binding characteristics of platelet 5-hydroxytryptamine receptors or of platelet alpha 2-adrenoceptors. Because the reduced 3H-imipramine binding capacity was found in classical migraineurs who were investigated between attacks, it may reflect a predisposition to migraine rather than being a consequence of attacks.
Blood Platelets↗
Autonomic dysaesthesia due to ergot toxicity.
Explore the source record for details and available documents.
Adult↗
Use of pizotifen in severe migraine: a long-term study.
Severe migraine attacks in 47 patients who were unresponsive to clonidine hydrochloride were treated with 1.5 mg pizotifen for a mean period of 6 month. The attack incidence, duration and severity were more than halved in 64% (30 patients), 25% becoming headache-free. Side-effects were not serious but weight gain was a problem in some subjects. Pizotifen administration allowed withdrawal of methysergide and ergotamine compounds without rebound headache. It appeared specially remedial in those whose migraine could be triggered by dietary factors. Follow-up 22 patients at 15 months confirmed these findings, 48.6% remaining 'improved' by the criteria of the trial (28% headache-free), and underlined the marked reduction in symptomatic drugs required and the absence of toxicity in long-term treatment.
Adult↗